Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Gastric Cancer

Free Subscription Articles published in Br J Cancer Retrieve available abstracts of 68 articles: HTML format Text format

Single Articles

March 2010
1. TSUJIURA M , Ichikawa D, Komatsu S, Shiozaki A, et al
   Circulating microRNAs in plasma of patients with gastric cancers.
   Br J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2010
2. SHINTO O , Yashiro M, Kawajiri H, Shimizu K, et al
   Inhibitory effect of a TGFbeta receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells.
   Br J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. KATO Y , Yashiro M, Noda S, Tendo M, et al
   Establishment and characterization of a new hypoxia-resistant cancer cell line, OCUM-12/Hypo, derived from a scirrhous gastric carcinoma.
   Br J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. TEBBUTT NC , Cummins MM, Sourjina T, Strickland A, et al
   Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial.
   Br J Cancer. 2010;102:475-81.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
5. SKIPWORTH RJ , Deans DA, Tan BH, Sangster K, et al
   Plasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancer.
   Br J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. JEON TY , Han ME, Lee YW, Lee YS, et al
   Overexpression of stathmin1 in the diffuse type of gastric cancer and its roles in proliferation and migration of gastric cancer cells.
   Br J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. KAMEDA C , Nakamura M, Tanaka H, Yamasaki A, et al
   Oestrogen receptor-alpha contributes to the regulation of the hedgehog signalling pathway in ERalpha-positive gastric cancer.
   Br J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. LORDICK F , Luber B, Lorenzen S, Hegewisch-Becker S, et al
   Cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric cancer: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).
   Br J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   November 2009
9. YAGHOOBI M , Bijarchi R, Narod SA
   Family history and the risk of gastric cancer.
   Br J Cancer. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   October 2009
10. PINTO C , Di Fabio F, Barone C, Siena S, et al
    Phase II study of cetuximab in combination with cisplatin and docetaxel in patients with untreated advanced gastric or gastro-oesophageal junction adenocarcinoma (DOCETUX study).
    Br J Cancer. 2009;101:1261-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
11. SEMBA S , Kodama Y, Ohnuma K, Mizuuchi E, et al
    Direct cancer-stromal interaction increases fibroblast proliferation and enhances invasive properties of scirrhous-type gastric carcinoma cells.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. BELIEN JA , Buffart TE, Gill AJ, Broeckaert MA, et al
    Gross genomic damage measured by DNA image cytometry independently predicts gastric cancer patient survival.
    Br J Cancer. 2009;101:1011-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. YASHIRO M , Shinto O, Nakamura K, Tendo M, et al
    Effects of VEGFR-3 phosphorylation inhibitor on lymph node metastasis in an orthotopic diffuse-type gastric carcinoma model.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
14. LI J , Ng EK, Ng YP, Wong CY, et al
    Identification of retinoic acid-regulated nuclear matrix-associated protein as a novel regulator of gastric cancer.
    Br J Cancer. 2009;101:691-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
15. BOYSEN T , Mohammadi M, Melbye M, Hamilton-Dutoit S, et al
    EBV-associated gastric carcinoma in high- and low-incidence areas for nasopharyngeal carcinoma.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
16. MOHRI Y , Mohri T, Wei W, Qi YJ, et al
    Identification of macrophage migration inhibitory factor and human neutrophil peptides 1-3 as potential biomarkers for gastric cancer.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. KIM Y , Shin A, Gwack J, Ko KP, et al
    Epstein-Barr virus antibody level and gastric cancer risk in Korea: a nested case-control study.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. IWATSUKI M , Fukagawa T, Mimori K, Nakanishi H, et al
    Bone marrow and peripheral blood expression of ID1 in human gastric carcinoma patients is a bona fide indicator of lymph node and peritoneal metastasis.
    Br J Cancer. 2009;100:1937-42.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. STARLING N , Okines A, Cunningham D, Allum W, et al
    A phase II trial of preoperative chemotherapy with epirubicin, cisplatin and capecitabine for patients with localised gastro-oesophageal junctional adenocarcinoma.
    Br J Cancer. 2009;100:1725-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
20. DUAN L , Wu AH, Sullivan-Halley J, Bernstein L, et al
    Passive smoking and risk of oesophageal and gastric adenocarcinomas.
    Br J Cancer. 2009;100:1483-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
21. BOEGL M , Prinz C
    CD133 expression in different stages of gastric adenocarcinoma.
    Br J Cancer. 2009;100:1365-6.
    PubMed     Text format     Related articles   
    
    
    
22. POULSEN AH , Christensen S, McLaughlin JK, Thomsen RW, et al
    Proton pump inhibitors and risk of gastric cancer: a population-based cohort study.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
23. HIRATA Y , Ogasawara N, Sasaki M, Mizushima T, et al
    BCL6 degradation caused by the interaction with the C-terminus of pro-HB-EGF induces cyclin D2 expression in gastric cancers.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. KIM JS , Kim MA, Kim TM, Lee SH, et al
    Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival.
    Br J Cancer. 2009;100:732-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
25. MURAYAMA T , Inokuchi M, Takagi Y, Yamada H, et al
    Relation between outcomes and localisation of p-mTOR expression in gastric cancer.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. ROHWER N , Lobitz S, Daskalow K, Jons T, et al
    HIF-1alpha determines the metastatic potential of gastric cancer cells.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. BERTUCCIO P , Praud D, Chatenoud L, Lucenteforte E, et al
    Dietary glycemic load and gastric cancer risk in Italy.
    Br J Cancer. 2009;100:558-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. ABNET CC , Freedman ND, Kamangar F, Leitzmann MF, et al
    Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis.
    Br J Cancer. 2009;100:551-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
29. BARROS-SILVA JD , Leitao D, Afonso L, Vieira J, et al
    Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. YING J , Poon FF, Yu J, Geng H, et al
    DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancers.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. ANDERS M , Vieth M, Rocken C, Ebert M, et al
    Loss of the coxsackie and adenovirus receptor contributes to gastric cancer progression.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. DEANS DA , Tan BH, Wigmore SJ, Ross JA, et al
    The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer.
    Br J Cancer. 2009;100:63-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. VERSCHUUR EM , Steyerberg EW, Tilanus HW, Polinder S, et al
    Nurse-led follow-up of patients after oesophageal or gastric cardia cancer surgery: a randomised trial.
    Br J Cancer. 2009;100:70-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. HAN SW , Oh DY, Im SA, Park SR, et al
    Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2008
35. OHTA H , Aoyagi K, Fukaya M, Danjoh I, et al
    Cross talk between hedgehog and epithelial-mesenchymal transition pathways in gastric pit cells and in diffuse-type gastric cancers.
    Br J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. KITA Y , Fukagawa T, Mimori K, Kosaka Y, et al
    Expression of uPAR mRNA in peripheral blood is a favourite marker for metastasis in gastric cancer cases.
    Br J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2008
37. BUFFART TE , Overmeer RM, Steenbergen RD, Tijssen M, et al
    MAL promoter hypermethylation as a novel prognostic marker in gastric cancer.
    Br J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. CATALANO V , Graziano F, Santini D, D'Emidio S, et al
    Second-line chemotherapy for patients with advanced gastric cancer: who may benefit?
    Br J Cancer. 2008;99:1402-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. CHENG YY , Jin H, Liu X, Siu JM, et al
    Fibulin 1 is downregulated through promoter hypermethylation in gastric cancer.
    Br J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2008
40. LEE HE , Chae SW, Lee YJ, Kim MA, et al
    Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer.
    Br J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
41. MURRAY D , Horgan G, Macmathuna P, Doran P, et al
    NET1-mediated RhoA activation facilitates lysophosphatidic acid-induced cell migration and invasion in gastric cancer.
    Br J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. TAKENO A , Takemasa I, Doki Y, Yamasaki M, et al
    Integrative approach for differentially overexpressed genes in gastric cancer by combining large-scale gene expression profiling and network analysis.
    Br J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. RAO S , Cunningham D
    Survival from cancer of the stomach in England and Wales up to 2001.
    Br J Cancer. 2008;99 Suppl 1:S19-20.
    PubMed     Text format     Related articles   
    
    
    
44. MITRY E , Rachet B, Quinn MJ, Cooper N, et al
    Survival from cancer of the stomach in England and Wales up to 2001.
    Br J Cancer. 2008;99 Suppl 1:S16-8.
    PubMed     Text format     Related articles   
    
    
    
45. SENAPATI S , Chaturvedi P, Sharma P, Venkatraman G, et al
    Deregulation of MUC4 in gastric adenocarcinoma: potential pathobiological implication in poorly differentiated non-signet ring cell type gastric cancer.
    Br J Cancer. 2008;99:949-56.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. SCHONNEMANN KR , Jensen HA, Yilmaz M, Jensen BY, et al
    Phase II study of short-time oxaliplatin, capecitabine and epirubicin (EXE) as first-line therapy in patients with non-resectable gastric cancer.
    Br J Cancer. 2008;99:858-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. RAO S , Starling N, Cunningham D, Benson M, et al
    Phase I study of epirubicin, cisplatin and capecitabine plus matuzumab in previously untreated patients with advanced oesophagogastric cancer.
    Br J Cancer. 2008;99:868-74.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2008
48. SCHONNEMANN KR , Jensen HA, Yilmaz M, Jensen BV, et al
    Phase II study of short-time oxaliplatin, capecitabine and epirubicin (EXE) as first-line therapy in patients with non-resectable gastric cancer.
    Br J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2008
49. LEE JL , Kang YK, Kang HJ, Lee KH, et al
    A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
    Br J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. SUZUKI S , Sasajima K, Sato Y, Watanabe H, et al
    MAGE-A protein and MAGE-A10 gene expressions in liver metastasis in patients with stomach cancer.
    Br J Cancer. 2008;99:350-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2008
51. SMITH LM , Nesterova A, Ryan MC, Duniho S, et al
    CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers.
    Br J Cancer. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2008
52. CASTELL F , Cook GJ
    Quantitative techniques in 18FDG PET scanning in oncology.
    Br J Cancer. 2008;98:1597-601.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. KIM MS , Jeong EG, Yoo NJ, Lee SH, et al
    Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias.
    Br J Cancer. 2008;98:1533-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2008
54. BAHMANYAR S , Lambe M, Zendehdel K, Nyren O, et al
    Parity and risk of stomach cancer by sub-site: a national Swedish study.
    Br J Cancer. 2008;98:1295-300.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2008
55. PARK SR , Kim HK, Kim CG, Choi IJ, et al
    Phase I/II study of S-1 combined with weekly docetaxel in patients with metastatic gastric carcinoma.
    Br J Cancer. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. WEI J , Zou Z, Qian X, Ding Y, et al
    ERCC1 mRNA levels and survival of advanced gastric cancer patients treated with a modified FOLFOX regimen.
    Br J Cancer. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. KUBOTA T
    The role of S-1 in the treatment of gastric cancer.
    Br J Cancer. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. MCKERNAN M , McMillan DC, Anderson JR, Angerson WJ, et al
    The relationship between quality of life (EORTC QLQ-C30) and survival in patients with gastro-oesophageal cancer.
    Br J Cancer. 2008;98:888-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. GOROUHI F , Islami F, Bahrami H, Kamangar F, et al
    Tumour-necrosis factor-A polymorphisms and gastric cancer risk: a meta-analysis.
    Br J Cancer. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2008
60. LEE MK , Lee KM, Bae JM, Kim S, et al
    Employment status and work-related difficulties in stomach cancer survivors compared with the general population.
    Br J Cancer. 2008;98:708-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. GRIFFITHS EA , Pritchard SA, McGrath SM, Valentine HR, et al
    Hypoxia-associated markers in gastric carcinogenesis and HIF-2alpha in gastric and gastro-oesophageal cancer prognosis.
    Br J Cancer. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. OTSUBO T , Akiyama Y, Yanagihara K, Yuasa Y, et al
    SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis.
    Br J Cancer. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2008
63. KANG HJ , Chang HM, Kim TW, Ryu MH, et al
    A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancer.
    Br J Cancer. 2008;98:316-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. MATSUBARA J , Nishina T, Yamada Y, Moriwaki T, et al
    Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer.
    Br J Cancer. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. KIM JG , Sohn SK, Chae YS, Song HS, et al
    Multicenter phase II study of docetaxel plus oxaliplatin combination chemotherapy in patients with advanced gastric cancer: Daegu Gyeongbuk Oncology Group.
    Br J Cancer. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
66. WU CW , Chiou JM, Ko FS, Lo SS, et al
    Quality of life after curative gastrectomy for gastric cancer in a randomised controlled trial.
    Br J Cancer. 2008;98:54-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. KATSURAGI K , Yashiro M, Hirakawa K
    Reply: Identification of isolated tumour cells by detection of CEA and CK mRNA in peritoneal lavage fluid of gastric cancer patients.
    Br J Cancer. 2008;.
    PubMed     Text format     Related articles   
    
    
    
68. DEANS DA , Wigmore SJ, Gilmour H, Tisdale MJ, et al
    Reply: Expression of the proteolysis-inducing factor core-peptide mRNA is upregulated in both tumour and adjacent normal tissue in gastrooesophageal malignancy.
    Br J Cancer. 2008;98:243.
    PubMed     Text format     Related articles   
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: